)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
LivaNova
LivaNova (LIVN) investor relations material
LivaNova Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary25 Feb, 2026
Executive summary
Achieved double-digit reported and organic revenue growth for full-year 2025, with continued operating margin expansion and strong adjusted EPS and free cash flow growth.
Robust performance in Cardiopulmonary and Neuromodulation/Epilepsy segments, driven by strong consumables demand, new system sales, and progress on strategic initiatives.
Advanced innovation in OSA, digital health, and neuromodulation, including FDA approval for a cloud-based digital health platform and increased Medicare reimbursement for VNS Therapy.
Strengthened leadership team and organizational capabilities, including key appointments for OSA commercialization.
Published positive clinical outcomes for VNS Therapy in depression and RECOVER study durability data.
Financial highlights
Full-year 2025 revenue reached $1.39B, up 10.7% reported and 11% organically; Q4 2025 revenue was $361M, up 9.5% year-over-year on a constant currency and organic basis.
Adjusted diluted EPS for 2025 was $3.90, up 15% year-over-year; Q4 adjusted diluted EPS was $0.86.
Adjusted gross margin for 2025 was 68.6%; adjusted operating margin was 20.6%.
Adjusted free cash flow for 2025 was $183M, with an 85% conversion rate; year-end cash balance was $636M.
Significant debt reduction and early repayments improved balance sheet flexibility.
Outlook and guidance
2026 revenue growth expected between 6%-7% on a constant currency basis, with a 1% FX tailwind.
Adjusted operating income margin forecasted at 20%-21%; adjusted diluted EPS projected at $4.15-$4.25.
Adjusted free cash flow expected between $160M-$180M; capital spending planned at $120M for capacity expansion and IT.
Cardiopulmonary revenue projected to grow 7%-8%; epilepsy/neuromodulation revenue expected to grow 5.5%-6.5%.
Continued investment in innovation, OSA product development, and pursuit of CMS coverage for VNS Therapy in DTD.
VNS DRE reimbursement: expected penetration
OSA market strategy: expected growth drivers
SNIA liability: future cash flow implications
Expected volume impact from VNS reimbursement?
PolySync's impact on OSA responder rates?
Essenz penetration vs. oxygenator capacity growth drivers
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next LivaNova earnings date
Q1 20266 May, 2026
LivaNova
Next LivaNova earnings date
Q1 20266 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
LivaNova PLC is a global medical technology company that develops and manufactures devices for use in cardiovascular and neuromodulation therapies. The company’s products are designed to address critical conditions such as heart failure, obstructive sleep apnea, and epilepsy. LivaNova’s cardiovascular segment focuses on cardiac surgery and advanced circulatory support, while its neuromodulation segment offers devices for treating neurological disorders. The company is headquartered in London, England, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage